Fundz

Hep Gene, Inc. reported raising $25,200 in an initial SEC Form D filing, from an offering of $1.3 Million

PRIVATEMar 09, 2020$25.2K of $1.3M raised

Amount Raised

$25,200

$25,200 sold, per SEC Form D (first sale Mar 9, 2020)

Round Type

Pre-Seed

FairfieldBiotechnology

Quick answer

HepGene, Inc. raised $25,200 in a Pre-Seed round, dated March 9, 2020. HepGene, Inc. is based in Fairfield, Connecticut, United States.

How much did HepGene, Inc. raise?
HepGene, Inc. raised $25,200 in a Pre-Seed round on March 9, 2020.
Where is HepGene, Inc. based and how big is it?
HepGene, Inc. is based in Fairfield, Connecticut, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as HepGene, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Harvard Apparatus Regenerative Technology raised $2.2M on April 23, 2020.
  • Gibson Oncology raised $3.8M (Seed) on April 23, 2020.
  • Accent Therapeutics raised $63M (Series B) on April 23, 2020.
  • Cytovale raised an undisclosed amount (Funding Round) on April 23, 2020.
  • Atai Life Sciences N.V raised $24M (Convertible Note) on April 23, 2020.
  • careviso (Formerly CMT Solutions) raised $3.6M (Seed) on April 22, 2020.

Who to call at HepGene, Inc., and when

A new round usually means HepGene, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HepGene, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HepGene, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HepGene, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HepGene, Inc.

Location

680 STILLSON ROAD

Fairfield, Connecticut, United States

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HepGene, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for HepGene, Inc.'s next move

See what Strategic adds

HepGene, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.